KCA

Dr. Yufei Wang received a 2022 KCA Trailblazer Award for her research on "Design of CAIX Targeted Fine-Tuned Immune Restoring Safe (FIS) CAR-T Cell Therapy for Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)". Dr. Wang is a postdoctoral fellow at the Dana-Farber Cancer Institute. We spoke with Dr. Wang about her work and the impact it can have on people…

Dr. Sheldon Holder received a 2022 KCA Trailblazer Award for his research on the "Exploration of the causes and effects of increased PIM1 kinase activity in renal cell carcinoma". Dr. Holder is a physician-scientist at The Legorreta Cancer Center at Brown University. We spoke with Dr. Holder about his work and the impact it can have on people with kidney…

Dr. Erin Tagai received a 2022 KCA Psychosocial Focus Award for her research on "Improving patient-reported outcomes for renal cancer patients on active surveillance." Dr. Tagai is an Assistant Research Professor at Fox Chase Cancer Center in Philadelphia, Pennsylvania and a health services researcher focused on the development and implementation of clinic-based strategies to improve patient-reported outcomes across the cancer…

Dr. David Braun received a 2022 KCA Trailblazer Award for his research on “Dissecting the immunobiology of chromophobe renal cell carcinoma using single-cell transcriptomics." Dr. Braun is a medical oncologist and an Assistant Professor of Medicine, Pathology, and Urology, and the Goodman and Gilman Yale Scholar at the Yale School of Medicine. We spoke with Dr. Braun about his work…

Dr. Srinivas Viswanathan received a 2022 KCA Trailblazer Award for his research on "Advancing a Cell Surface Therapeutic Target in Translocation Renal Cell Carcinoma. Dr. Viswanathan is a medical oncologist at the Dana-Farber Cancer Institute. We spoke with Dr. Viswanathan about his work and the impact it can have on people with kidney cancer. Can you summarize your research study?…

Dr. Pooja Ghatalia received a 2022 KCA Trailblazer Award for her research on "Comparison of immune microenvironment between patients of African and European ancestry with renal cell carcinoma." Dr. Ghatalia is a medical oncologist and researcher at Fox Chase Cancer Center in Philadelphia, Pennsylvania. She previously received a KCA research grant in 2017. We spoke with Dr. Ghatalia about her…

Dr. Nazli Dizman received a 2022 KCA Trailblazer Award for her research on the "Impact of CBM588 on metabolomic profile in patients with metastatic renal cell carcinoma (mRCC)". Dr. Dizman is an internal medicine resident at the Yale University School of Medicine. We spoke with her about her work and the impact it can have on people with kidney cancer. What…

Kathryn Nelson is an RN at the Mayo Clinic in Rochester, Minnesota and a member of the KCA’s Clinical Advisory Board. In this Q & A, she talks about what radiation therapy is and when and why it might be used in the course of kidney cancer treatment. Kathryn Nelson, RN What is radiation therapy? Radiation therapy uses carefully targeted and…

The Kidney Cancer Association (KCA) awarded seven grants to researchers pursuing projects with the potential to improve kidney cancer treatment and care. “This year we restructured the KCA’s grant program to benefit up-and-coming researchers for whom this type of funding at this point in their careers would make a significant difference,” said Dr. Daniel George, a medical oncologist at the…

Welcome to our series on "Clinical Perspectives." Read the introduction. Dr. Daniel George By D’Ann George, PhD, Medical Writer In the old paradigm, based on chemotherapy, when a tumor grew while being treated with a drug, that meant the drug was no longer working to control the cancer and that was it. Time to move on to another approach —…